Johnson & Johnson (JNJ) call put ratio 1 to 1 into EPS and outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Johnson & Johnson (JNJ) PT Lowered to $144 at RBC Capital
January 23, 2019 6:53 AM ESTRBC Capital analyst Glenn Novarro lowered the price target on Johnson & Johnson (NYSE: JNJ) to $144.00 (from $155.00) while maintaining a Outperform rating.
Novarro notes management has set conservative 2019 guidance. As such, he expects the 'beat and raises' to continue.
... More